JD Health International Inc.
JD Health International Inc. (JDHIF) Stock Overview
Explore JD Health International Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
11.7B
P/E Ratio
31.36
EPS (TTM)
$0.12
ROE
0.05%
JDHIF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of JD Health International Inc. (JDHIF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.50.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 31.36 and a market capitalization of 11.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Enlin Jin
3,564
Jingdong Headquarters, Beijing
2020